Torsemide 20 mg Equivalent Dose to Furosemide
Torsemide 20 mg is approximately equivalent to furosemide 80 mg based on the standard conversion ratio of 1:4 (torsemide:furosemide). 1
Standard Dose Conversion Ratio
- The established conversion ratio is furosemide 40 mg = torsemide 10 mg, which translates to a 4:1 equivalence (furosemide:torsemide). 1
- Using this ratio, torsemide 20 mg corresponds to furosemide 80 mg. 1
Evidence Supporting the 4:1 Conversion
- The TRANSFORM-Mechanism trial demonstrated that a dose equivalence of approximately 4:1 resulted in similar natriuresis between furosemide and torsemide, whereas the commonly used 2:1 ratio resulted in substantially greater natriuresis with torsemide. 2
- When clinicians used an average 2:1 conversion (the historical standard), torsemide produced significantly greater sodium excretion than furosemide, suggesting this ratio leads to relative over-dosing of torsemide. 2
- A controlled trial in heart failure patients found that torsemide 10 mg and furosemide 40 mg yielded comparable changes in 24-hour electrolyte excretion, supporting the 4:1 ratio. 3
Clinical Context and Nuances
- Torsemide has superior oral bioavailability (approximately 80%) compared to furosemide, which has variable absorption that can be delayed in heart failure patients due to gut wall edema. 4, 3
- Despite better bioavailability, kidney bioavailability (the proportion of drug delivered to the tubular site of action) was actually lower with torsemide (17.1%) than furosemide (24.8%) in the TRANSFORM-Mechanism trial. 2
- Furosemide demonstrated a longer duration of kidney drug delivery and natriuresis compared to torsemide, contrary to the theoretical pharmacokinetic advantage of torsemide's longer half-life. 2
Practical Dosing Implications
- For patients switching from furosemide 80 mg daily to torsemide, the appropriate dose is 20 mg daily using the 4:1 ratio. 1
- Torsemide's 12-16 hour duration of action allows for convenient once-daily dosing, compared to furosemide's 6-8 hour duration which may require twice-daily administration at higher doses. 1
- Both drugs should be administered in the morning to minimize nocturia and improve adherence. 1
Important Caveats
- The higher diuretic doses with torsemide (when using a 2:1 ratio) resulted in greater neurohormonal activation (increased renin, aldosterone, and norepinephrine) and mild kidney dysfunction without improving plasma volume or body weight compared to furosemide. 2
- Clinical outcomes (all-cause mortality, heart failure hospitalization) did not differ between torsemide and furosemide in the large TRANSFORM-HF trial, suggesting no superiority of one agent over the other when dosed appropriately. 5, 6
- Higher loop diuretic doses (regardless of agent) were independently associated with worse clinical outcomes following heart failure hospitalization, emphasizing the importance of using the lowest effective dose. 7
Monitoring After Conversion
- Check serum electrolytes (potassium, sodium) and renal function within 1-2 weeks after switching diuretics, then at 3 months and 6-month intervals. 8
- Monitor daily weights with a target loss of 0.5-1.0 kg daily during active diuresis. 1
- Assess for signs of over-diuresis (hypotension, rising creatinine, hypovolemia) or under-diuresis (persistent edema, weight gain). 8